Abstract
Colorectal cancer (CRC) is a major cause of morbidity and mortality from cancers in the United States. Recent studies have revealed the paradigm in which sequential genetic changes (mutations) result in the progression from normal colonic tissues to frank carcinoma. In particular, the study of hereditary colorectal cancer and polyposis syndromes such as familial adenomatous polyposis and hereditary nonpolyposis colon cancer has contributed enormously to the understanding of the pathogenesis of CRC. Here we describe some of the common genetic pathways in CRC and the mechanisms of action for some of the key genes involved in the formation of CRC. The understanding of the genetic pathways and functions in CRC may lead to the development of novel therapeutic approaches for treating this deadly disease.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
American Cancer Society: Cancer Facts & Figures 2005 http://www.cancer.org/downloads/STTCAFF2005f4PWSecured.pdf. Accessed January 31, 2006.
Hisamuddin IM, Yang VW: Genetics of colorectal cancer. MedGenMed 2004, 6:13–19.
Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759–767.
Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996, 87:159–170.
Sparks AB, Morin PJ, Vogelstein B, et al.: Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998, 58:1130–1134.
de la Chapelle A: Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004, 4:769–780. This excellent review article discussed the various genetic mechanisms that predispose to colorectal cancer, including those with low-penetrance.
Kinzler KW, Vogelstein B: Landscaping the cancer terrain. Science 1998, 280:1036–1037.
Cruz-Correa M, Giardiello FM: Familial adenomatous polyposis. Gastrointest Endosc 2003, 58:885–894.
Kinzler KW, Nilbert MC, Su LK, et al.: Identification of FAP locus genes from chromosome 5q21. Science 1991, 253:661–665.
Nishisho I, Nakamura Y, Miyoshi Y, et al.: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991, 253:665–669.
Groden J, Thliveris A, Samowitz W, et al.: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66:589–600.
Soravia C, Berk T, Madlensky L, et al.: Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet 1998, 62:1290–1301.
Laken SJ, Petersen GM, Gruber SB, et al.: Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997, 17:79–83.
Gruber SB, Petersen GM, Kinzler KW, et al.: Cancer, crash sites, and the new genetics of neoplasia. Gastroenterology 1999, 116:210–212.
Sieber OM, Lipton L, Crabtree M, et al.: Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003, 348:791–799. This article described the Identification of biallelic mutation of MYH as the cause of classic adenomatous polyposis syndrome in the absence of any APC mutations.
Halford SE, Rowan AJ, Lipton L, et al.: Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol 2003, 162:1545–1548.
Mecklin JP, Jarvinen HJ: Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer). Cancer 1991, 68:1109–1112.
Papadopoulos N, Lindblom A: Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 1997, 10:89–99.
Markowitz S, Wang J, Myeroff L, et al.: Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995, 268:1336–1338.
Souza RF, Appel R, Yin J, et al.: Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet 1996, 14:255–257.
Rampino N, Yamamoto H, Ionov Y, et al.: Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997, 275:967–969.
Hemminki A, Markie D, Tomlinson I, et al.: A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998, 391:184–187.
Jenne DE, Reimann H, Nezu J, et al.: Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998, 18:38–43.
Sayed MG, Ahmed AF, Ringold JR, et al.: Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol 2002, 9:901–906.
Olschwang S, Serova-Sinilnikova OM, Lenoir GM, et al.: PTEN germ-line mutations in juvenile polyposis coli. Nat Genet 1998, 18:12–14.
Marsh DJ, Kum JB, Lunetta KL, et al.: PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet 1999, 8:1461–1472.
Yang VW: APC as a checkpoint gene: the beginning or the end? Gastroenterology 2002, 123:935–939.
Midgley CA, White S, Howitt R, et al.: APC expression in normal human tissues. J Pathol 1997, 181:426–433.
Nathke IS: The adenomatous polyposis coli protein: the Achilles heel of the gut epithelium. Annu Rev Cell Dev Biol 2004, 20:337–366. This paper gave an excellent review of the biochemical and cell biologic mechanisms of action of the tumor suppressor APC.
van Es JH, Giles RH, Clevers HC: The many faces of the tumor suppressor gene APC. Exp Cell Res 2001, 264:126–134.
Reya T, Clevers H: Wnt signaling in stem cells and cancer. Nature 2005, 434:843–850.
Gregorieff A, Clevers H: Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 2005, 19:877–890.
Bhanot P, Brink M, Samos CH, et al.: A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 1996, 382:225–230.
Tamai K, Semenov M, Kato Y, et al.: LDL-receptor-related proteins in Wnt signal transduction. Nature 2000, 407:530–535.
Pinson KI, Brennan J, Monkley S, et al.: An LDL-receptor- related protein mediates Wnt signalling in mice. Nature 2000, 407:535–538.
Behrens J, von Kries JP, Kuhl M, et al.: Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996, 382:638–642.
He TC, Sparks AB, Rago C, et al.: Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509–1512.
Tetsu O, McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422–426.
Miyoshi Y, Nagase H, Ando H, et al.: Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1992, 1:229–233.
Jin LH, Shao QJ, Luo W, et al.: Detection of point mutations of the Axin1 gene in colorectal cancers. Int J Cancer 2003, 107:696–699.
Webster MT, Rozycka M, Sara E, et al.: Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding. Genes Chromosomes Cancer 2000, 28:443–453.
Smith KJ, Levy DB, Maupin P, et al.: Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res 1994, 54:3672–3675.
Su LK, Burrell M, Hill DE, et al.: APC binds to the novel protein EB1. Cancer Res 1995, 55:2972–2977.
Matsumine A, Ogai A, Senda T, et al.: Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein. Science 1996, 272:1020–1023.
Fodde R, Kuipers J, Rosenberg C, et al.: Mutations in the APC tumor suppressor gene cause chromosomal instability. Nat Cell Biol 2001, 3:433–438.
Kaplan KB, Burds AA, Swedlow JR, et al.: A role for the adenomatous polyposis coli protein in chromosome segregation. Nat Cell Biol 2001, 3:429–432.
Leslie A, Stewart A, Baty DU, et al.: Chromosomal changes in colorectal adenomas: relationship to gene mutations and potential for clinical utility. Genes Chromosomes Cancer 2005, 45:126–135.
Hollstein M, Sidransky D, Vogelstein B, et al.: p53 mutations in human cancers. Science 1991, 253:49–53.
Baker SJ, Fearon ER, Nigro JM, et al.: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989, 244:217–221.
Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature 2000, 408:307–310.
Momand J, Zambetti GP, Olson DC, et al.: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992, 69:1237–1245.
Honda R, Yasuda H: Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. Embo J 1999, 18:22–27.
Wsierska-Gadek J, Horky M: How the nucleolar sequestration of p53 protein or its interplayers contributes to its (re)-activation. Ann N Y Acad Sci 2003, 1010:266–272.
Agarwal ML, Taylor WR, Chernov MV, et al.: The p53 network. J Biol Chem 1998, 273:1–4.
Harris SL, Levine AJ: The p53 pathway: positive and negative feedback loops. Oncogene 2005, 24:2899–2908. This article reviewed the various positive and negative mechanisms of regulation of the tumor suppressor p53’s activity.
el-Deiry WS, Tokino T, Velculescu VE, I et al.: WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817–825.
Taylor WR, Stark GR: Regulation of the G2/M transition by p53. Oncogene 2001, 20:1803–1815.
Hermeking H, Lengauer C, Polyak K, et al.: 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1997, 1:3–11.
Malumbres M, Barbacid M: RAS oncogenes: the first 30 years. Nat Rev Cancer 2003, 3:459–465.
Shields JM, Pruitt K, McFall A, et al.: Understanding Ras: “it ain’t over ’til it’s over.’” Trends Cell Biol 2000, 10:147–154.
Bos JL: Ras oncogenes in human cancer: a review. Cancer Res 1989, 49:4682–4689.
Andreyev HJ, Norman AR, Cunningham D, et al.: Kirsten ras mutations in patients with colorectal cancer: the “RASCAL II” study. Br J Cancer 2001, 85:692–696.
Rajagopalan H, Bardelli A, Lengauer C, et al.: Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 2002, 418:934.
Tuveson DA, Shaw AT, Willis NA, et al.: Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 2004, 5:375–387.
Janssen KP, el-Marjou F, Pinto D, et al.: Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. Gastroenterology 2002, 123:492–504.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hisamuddin, I.M., Yang, V.W. Molecular genetics of colorectal cancer: An overview. Curr colorectal cancer rep 2, 53–59 (2006). https://doi.org/10.1007/s11888-006-0002-2
Issue Date:
DOI: https://doi.org/10.1007/s11888-006-0002-2